You are here

Industry News

Advamed Smart Brief

April 20, 2018
A round of Series B financing brought in more than $10 million for Santa Cruz, Calif.-based Emboline, which makes the Embolin -More
April 20, 2018
Sensus Healthcare, a Boca Raton, Fla.-based company that makes low-energy photon X-ray systems for the treatment of nonmelano -More
April 20, 2018
A deal was reached by Biotronik with Aziyo Biologics to co-distribute Aziyo's CanGaroo bio-envelopes in the US.  -More
April 20, 2018
A three-year agreement was signed by Xtant Medical with Healthcare International Partners for the expansion of Xtant's produc -More
April 20, 2018
UgenTec and Serosep will partner to allow Serosep's EntericBio assay range to be included in UgenTec's FastFinder platform.  -More
April 20, 2018
Stephan Soyka was tapped to serve as managing director for B. Braun's Korean branch in Seoul, South Korea.  -More
April 20, 2018
The FDA granted Urotronic approval to conduct a pivotal trial of its Optilume drug-coated balloon, which is designed for trea -More
April 20, 2018
An application has been released by data analytics startup Trayt for use in monitoring behavioral and nonbehavioral symptoms  -More
April 20, 2018
The FDA granted Arthrosurface 510(k) clearance for its stemless total shoulder system, OVOMotion Shoulder Arthroplasty System -More
April 20, 2018
European regulators granted Fountain Valley, Calif.-based HeartStitch CE mark approval for its CoAp Pro device, which is inte -More

Industry News

Helius Medical Technologies, Inc.
NEWTOWN, PA.,  April 11, 2018 - Helius Medical Technologies, Inc. (“Helius” or the “Company”) today announced the pricing of an underwritten public offering of 2,141,900 shares of its Class A common stock and warrants to purchase 2,141,900 shares of its Class A common stock at a public offering price of US$7.47 per share and accompanying warrant, before underwriting discounts and commissions.  The net proceeds to the Company from this offering, after deducting the underwriting discounts,...
PR Newswire
California-based Myoscience, Inc. announced today that it received 510k clearance from the US FDA for Smart Tip with Nerve Stim, the latest innovative tip for Myoscience’s iovera° platform technology. With the FDA clearance for Smart Tip with Nerve Stim, physicians will be able to stimulate a nerve in advance of delivering iovera° cold therapy to the treatment area, reducing patient treatment times. Additionally, the use of Smart Tip with Nerve Stim enables physicians using iovera° to access...
Media Planet
It sometimes strikes without warning. People of any age, race, ethnicity and gender are at risk. In fact, it is the leading killer of both men and women in America. It is heart disease, and each year it claims the lives of over 600,000 Americans, accounting for one-quarter of all deaths in the United States. 
Boston Scientific
Boston Scientific commends the efforts of key champions in the U.S. House and Senate for their successful efforts to suspend the medical device tax, allowing the device industry to reinvest in work to benefit patients.
Sysmex America
LINCOLNSHIRE, ILL. – Nov. 8, 2017 – Sysmex America announced today that its Sysmex XW-100 received clearance from the U.S. Food and Drug Administration (FDA)—making it the first Clinical Laboratory Improvement Amendments (CLIA)-waived, complete blood count (CBC) system. Once prepared for each day’s use, the XW-100 will allow health care professionals to provide patients with blood test results in as few as three minutes.